Literature DB >> 10837808

Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia.

R E Schmidt1, D A Dorsey, K A Roth, C A Parvin, L Hounsom, D R Tomlinson.   

Abstract

Diabetic autonomic neuropathy results in significant morbidity and mortality. Both diabetic humans and experimental animals show neuroaxonal dystrophy of autonomic nerve terminals, particularly in the prevertebral superior mesenteric ganglia (SMG) and celiac ganglia (CG) which innervate the hyperplastic/hypertrophic diabetic small intestine. Previously, investigators suggested that disturbances in ganglionic nerve growth factor (NGF) content or transport might play a pathogenetic role in diabetic autonomic pathology. To test this hypothesis, we measured NGF content and NGF receptor expression, p75(NTR) (low affinity neurotrophin receptor) and trkA (high affinity NGF receptor), in control and diabetic rat SMG, CG and superior cervical ganglia (SCG). Surprisingly, rather than a decrease, we observed an approximate doubling of NGF content in the diabetic SMG and CG, a result which reflects increased NGF content in the hyperplastic diabetic alimentary tract. No change in NGF content was detected in the diabetic SCG which is relatively spared in experimental diabetic autonomic neuropathy. NGF receptor expression was not consistently altered in any of the autonomic ganglia. These observations suggest that increased NGF content in sympathetic ganglia innervating the diabetic alimentary tract coupled with intact receptor expression may produce aberrant axonal sprouting and neuroaxonal dystrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837808     DOI: 10.1016/s0006-8993(00)02281-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  The effects of age and streptozotocin diabetes on the sympathetic innervation in the rat penis.

Authors:  J F B Morrison; D J Pallot; R Sheen; S Dhanasekaran; E P K Mensah-Brown
Journal:  Mol Cell Biochem       Date:  2006-08-31       Impact factor: 3.396

2.  Impaired activation of celiac ganglion neurons in vivo after damage to their sympathetic nerve terminals.

Authors:  Thomas O Mundinger; Qi Mei; Gerald J Taborsky
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

3.  Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.

Authors:  Nigel A Calcutt; Karen L Allendoerfer; Andrew P Mizisin; Alicia Middlemas; Jason D Freshwater; Monica Burgers; Rigel Ranciato; Jean-Dominique Delcroix; Frederick R Taylor; Renee Shapiro; Kathy Strauch; Henryk Dudek; Thomas M Engber; Alphonse Galdes; Lee L Rubin; David R Tomlinson
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

4.  Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; John M Hayes; Yu Hong; Eva L Feldman
Journal:  J Neuropathol Exp Neurol       Date:  2009-11       Impact factor: 3.685

5.  Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.

Authors:  Joice M Cunha; Corinne G Jolivalt; Khara M Ramos; Joshua A Gregory; Nigel A Calcutt; Andrew P Mizisin
Journal:  Metabolism       Date:  2008-07       Impact factor: 8.694

Review 6.  Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.

Authors:  Will Whitmire; Mohammed Mh Al-Gayyar; Mohammed Abdelsaid; Bilal K Yousufzai; Azza B El-Remessy
Journal:  Mol Vis       Date:  2011-01-28       Impact factor: 2.367

7.  Temporal dystrophic remodeling within the intrinsic cardiac nervous system of the streptozotocin-induced diabetic rat model.

Authors:  Chantalle E Menard; Melanie Durston; Elena Zherebitskaya; Darrell R Smith; Darren Freed; Gordon W Glazner; Ganghong Tian; Paul Fernyhough; Rakesh C Arora
Journal:  Acta Neuropathol Commun       Date:  2014-06-04       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.